Billing That Matches the Complexity of Cancer Care

Drug administration billing is the financial core of most oncology practices, and getting it right requires detailed knowledge of infusion sequencing rules, concurrent drug administration coding, and the correct reporting of chemotherapy versus non-chemotherapy drug administration. The order in which drugs are administered, the distinction between push and infusion administration, and the correct reporting of each drug's billing code all affect reimbursement on every single visit. Medisure ensures that every drug administration encounter is coded based on exactly what was given and how, capturing the full reimbursement value of every infusion visit without exception.

For practices that purchase and administer oncology drugs directly, the buy-and-bill model represents a significant portion of practice revenue and an equally significant billing risk. Incorrect drug codes, wrong dosage billing, missing NDC numbers, and prior authorization failures can all result in costly denials on high-value drug claims. At Medisure, we manage oncology drug billing with the precision and attention it demands, ensuring that every drug administered is billed with the correct HCPCS code, the right units, and the supporting documentation needed to protect your reimbursement on every claim.

In oncology, treatment delays have consequences that go far beyond finances. A missing prior authorization for a chemotherapy regimen or an immunotherapy drug can delay a patient's treatment and put your practice's revenue at risk simultaneously. Medisure manages the prior authorization process with urgency and thoroughness, tracking every active authorization, following up on pending approvals, and flagging any issues immediately so that your clinical team can address them before treatment is scheduled. This coordination between the authorization process and the billing workflow keeps your oncology practice running smoothly and your revenue protected.

Oncology claims are denied more frequently than almost any other specialty, largely due to the high cost of cancer treatments and the aggressive payer scrutiny that comes with it. Medical necessity disputes, step therapy requirements, drug coverage denials, and authorization failures are all common in oncology billing. At Medisure, we treat every denied oncology claim with the urgency and thoroughness it deserves. Our team responds to denials immediately, assembles the clinical and administrative documentation needed to support a strong appeal, and follows through until every legitimate claim is paid.

Oncologists and their teams pour an extraordinary amount of dedication into their patients every single day. The revenue cycle that supports that work should be equally dedicated and thorough. At Medisure, we provide oncology practices with a complete billing solution that covers every service, every drug, every administration visit, and every follow-up encounter. You receive detailed monthly performance reports, a team that knows oncology billing inside and out, and a partner that is always working to protect and grow your revenue. With Medisure managing your billing, your practice can focus on what matters most: fighting for your patients.